JCRファーマ株式会社 FY2025 第三四半期決算説明会

This document records the content of the FY2025 Third Quarter Results Briefing Session of JCR Pharmaceuticals Co., Ltd., held on January 28, 2026. During this session, the company announced its financial results, reporting net sales of JPY 30.353 billion, operating profit of JPY 427 million, and profit attributable to owners of parent of JPY 1.744 billion, showing an increase compared to the same period last year. Key factors included an upfront payment from a contract with Italfarmaco and extraordinary income from a subsidy related to the Kobe Science Park Center API plant. The session included presentations and a Q&A segment, attended by analysts and investors.